Skip to main content
Back
Watch Compare

Beauty Health Co

Data quality: 100%
SKIN
Nasdaq Manufacturing Measuring & Analyzing Instruments
$0.92
▼ $0.01 (-0.74%)
Mkt Cap: 118.18 M
Price
$0.92
Mkt Cap
118.18 M
Day Range
$0.90 — $0.94
52-Week Range
$0.76 — $2.69
Volume
164,036
Open $0.90
50D / 200D Avg
$1.13
18.41% below
50D / 200D Avg
$1.57
41.21% below

Quick Summary

Key Takeaways

Revenue grew 3.70% annually over 5 years — modest growth
Debt/Equity of 5.53 — high leverage
Generating 37.18 M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 13.72%
Capital efficient — spends only 0.10% of revenue on capex

Growth

Revenue Growth (5Y)
3.70%
Below sector avg (9.35%)
Revenue (1Y)-10.02%
Earnings (1Y)N/A
FCF Growth (3Y)44.02%

Quality

Return on Equity
-13.63%
Above sector avg (-51.02%)
ROIC-3.69%
Net Margin-3.16%
Op. Margin-6.92%

Safety

Debt / Equity
5.53
Above sector avg (0.33)
Current Ratio4.98
Interest Coverage-1.08

Valuation

PE (TTM)
-12.41
Below sector avg (-1.98)
P/B Ratio1.80
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (44 peers)
Metric Stock Sector Median
P/E -12.4 -2.0
P/B 1.8 5.1
ROE % -13.6 -51.0
Net Margin % -3.2 -150.2
Rev Growth 5Y % 3.7 9.3
D/E 5.5 0.3

ETFs Holding This Stock

GSSC logo GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
0.02% weight
IWV logo IWV iShares Russell 3000 ETF
0.00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) -10.02% Revenue Growth (3Y) -13.06%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 3.70% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 300.79 M Net Income (TTM) -9.52 M
ROE -13.63% ROA -1.88%
Gross Margin 65.28% Operating Margin -6.92%
Net Margin -3.16% Free Cash Flow (TTM) 37.18 M
ROIC -3.69% FCF Growth (3Y) 44.02%
Safety
Debt / Equity 5.53 Current Ratio 4.98
Interest Coverage -1.08 Asset Turnover 0.59
Working Capital 246.46 M Tangible Book Value -98.82 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -12.41 Forward P/E N/A
P/B Ratio 1.80 P/S Ratio 0.39
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 31.46%
Market Cap 118.18 M Enterprise Value 481.57 M
Per Share
EPS (Diluted TTM) -0.16 Revenue / Share 2.35
FCF / Share 0.29 OCF / Share 0.29
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0.10% FCF Conversion -390.61%
SBC-Adj. FCF 18.23 M Growth Momentum -13.72

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2020
Revenue 300.79 M 334.29 M 397.99 M 365.88 M —
Net Income -9.52 M -29.10 M -100.12 M 44.38 M -1.11 M
EPS (Diluted) -0.16 -0.36 -0.76 -0.23 —
Gross Profit 196.36 M 182.30 M 155.11 M 250.34 M —
Operating Income -20.80 M -67.77 M -130.92 M -24.28 M -1.21 M
EBITDA — — — — —
R&D Expenses 5.63 M 6.30 M 10.10 M 8.44 M —
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 19.33 M 10.41 M 13.65 M — —
Income Tax 3.58 M -452,000.0 -1.77 M 648,000.0 —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2020
Total Assets 499.80 M 685.68 M 929.11 M 1.01 B 464.00 M
Total Liabilities 438.75 M 633.88 M 869.72 M 837.43 M 16.87 M
Shareholders' Equity 61.06 M 51.80 M 59.39 M 171.48 M 5.00 M
Total Debt — — — — —
Cash & Equivalents — — 523.03 M 568.20 M 3.27 M
Current Assets 309.52 M 477.12 M 698.25 M 789.10 M 3.90 M
Current Liabilities 186.28 M 68.15 M 115.01 M 73.12 M 765,497.0